Skip to content

FP7H2020HORIZON

Fundacion Para la Investigacion Medica Aplicada Fima

Country
ESSpain
Defence projects
0
Projects, all programmes
41
As coordinator
20
EU contribution (CORDIS)
EUR 17,346,139
Active
2008 to 2024

Projects

41 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
RNATRAINThe European non-coding RNA networkFP72013ParticipantEUR 237,682
LINCMHEMRole of DNA methylation in the regulation of lincRNAs in Hematological MalignanciesFP72013CoordinatorEUR 352,824
HOMAGEHeart OMics in AGEingFP72013ParticipantEUR 310,045
LYMFOXP1ROLE OF THE TRANSCRIPTION FACTOR FOXP1 IN B CELL FUNCTION AND LYMPHOMAGENESISFP72013CoordinatorEUR 230,037
IACTImmunostimulatory Agonist antibodies for Cancer TherapyFP72013ParticipantEUR 306,304
NMDAR-synprunThe roles of juvenile NMDA receptors in synapse maturation and elimination and their association with cognitionFP72013CoordinatorEUR 166,336
KRASMIRThe role of miRNAs in KRAS-driven Non-Small Cell Lung CancerFP72013CoordinatorEUR 100,000
CANCERLINCFunctional and Mecahnistic Roles of Large Intergenic Non-coding RNAs in CancerFP72012CoordinatorEUR 1,500,000
BRAINVECTORSFrom Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVVFP72012ParticipantEUR 45,653
ENDOGENOUS AEDSupply-rate depression as endogenous anti-epileptic mechanismFP72012ParticipantEUR 100,000
MetastasisEvaluation of metastatic and angiogenic potential of cancer stem-like cells in distinct mouse models for lung and liver metastasisFP72011CoordinatorEUR 167,066
AIPGENEAugmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent PorphyriaFP72011CoordinatorEUR 822,842
NAVICHEBNEW ADVANCED VACCINES IN CHRONIC HEPATITIS BFP72011CoordinatorEUR 100,000
MEDIAThe MEtabolic Road to DIAstolic Heart FailureFP72011ParticipantEUR 788,551
EU-MASCARAMarkers for Sub-Clinical Cardiovascular Risk AssessemntFP72011ParticipantEUR 314,124
CURELUNGDetermining (epi)genetic therapeutic signatures for improving lung cancer prognosisFP72011ParticipantEUR 280,024
HEPACUTEHost and viral factors in acute hepatitis CFP72010ParticipantEUR 172,500
NEURONAL SPECIFICITYLongitudinal analysis to study neurodegenerative diseases mechanisms in specific neuronal subtypesFP72009CoordinatorEUR 100,000
BRAINCAVNONHUMAN ADENOVIRUS VECTORS FOR GENE TRANSFER TO THE BRAINFP72008ParticipantEUR 268,474
ENCITEEuropean Network for Cell Imaging and Tracking ExpertiseFP72008ParticipantEUR 263,620

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.